MYGN Myriad Genetics, Inc.
Healthcare$3.85+0.79%ClosedMarket Cap: $363.6M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
1
Dispositions
3
Buy/Sell Ratio
0.33
Net Shares
-50,490
Shares Acquired
7,500
Shares Disposed
57,990
Total Bought ($)
$1.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu May 14 | Bisaro Paul | director | Buy | 7,500 | $3.69 | 97,441 |
| Mon May 04 | Donnelly Brian J | officer: Chief Commerical Officer | Sell | 55,975 | $4.80 | 568,363 |
| Wed Apr 15 | Verratti Mark | officer: Chief Operating Officer | Sell | 1,069 | $4.91 | 629,646 |
| Wed Apr 15 | Muzzey Dale | officer: Chief Scientific Officer | Sell | 946 | $4.91 | 326,310 |
| Mon Mar 23 | Wheeler Benjamin Richard | officer: Chief Financial Officer | Sell | 549 | $4.58 | 298,509 |
| Mon Mar 23 | Verratti Mark | officer: Chief Operating Officer | Sell | 2,055 | $4.58 | 630,715 |
| Mon Mar 23 | Muzzey Dale | officer: Chief Scientific Officer | Sell | 2,019 | $4.58 | 327,256 |
| Mon Mar 16 | Solaiman Shereen | officer: Chief People Officer | Sell | 8,899 | $4.66 | 273,585 |
| Mon Mar 16 | Solaiman Shereen | officer: Chief People Officer | Sell | 5,784 | $4.66 | 267,801 |
| Mon Mar 16 | Solaiman Shereen | officer: Chief People Officer | Sell | 173,196 | $0.00 | 282,484 |
| Mon Mar 16 | Haas Kevin Richard | officer: Chief Technology Officer | Sell | 8,382 | $4.66 | 180,022 |
| Mon Mar 16 | Haas Kevin Richard | officer: Chief Technology Officer | Sell | 6,412 | $4.66 | 195,920 |
| Mon Mar 16 | Haas Kevin Richard | officer: Chief Technology Officer | Sell | 4,161 | $4.66 | 191,759 |
| Mon Mar 16 | Haas Kevin Richard | officer: Chief Technology Officer | Sell | 3,355 | $4.66 | 188,404 |